Skip to main content
Valvular Heart DiseaseDiagnostics and screeningDigital healthDiagnostic test

What this study is

The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population.

Finally, the investigators are also aiming to investigate the association between signals obtained from PPG in the general population to cardioechographic findings such as, valvular heart disease, structural heart diseases, cardiomyopathies, pericardial disease etc.

What's being tested

  • Photoplethysmography

    Intervention · DIAGNOSTIC TEST

    Photoplethysmography (PPG) is a non-invasive technique that can detect volumetric changes in the peripheral blood. It only requires skin contact and relies on light absorption. PPG is a good indicator of the cardiovascular dynamics in the human body. PPG has been incorporated into various new smartphones and wearable devices such as, smartwatches and fitness wristbands making it readily available to all consumers. This sensor can record biometrics such as, heart rate, blood pressure, oxygen saturation, etc.

Study details

Official title
Photoplethysmography (PPG) to Predict Ejection Fraction and Other Echographic Data in the General Population
Sponsor
Tulane University
Conditions
Valvular Heart Disease · Pericardial Disease · Cardiomyopathies
Enrolling
500 people
Starts
2021-08-20
Est. completion
2026-12
Record
View on ClinicalTrials.gov ↗